When did the substantial loss of child linear growth occur?
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
04
04
2023
accepted:
23
08
2023
medline:
18
9
2023
pubmed:
14
9
2023
entrez:
14
9
2023
Statut:
epublish
Résumé
Epidemiological studies show that the height-for-age Z-scores (HAZ) falter dramatically shortly after birth until the end of the first two years. Understanding these changes in linear growth in the first two years can help us understand the critical period of child linear growth and propose interventions. This study objectives were to describe the pattern of linear growth faltering and analyze the changes in length-for-age Z-scores (LAZs) throughout the first two years based on birthweight and length status. This study analyzed 408 children, participants in Longitudinal Study on Child Growth and Development in Bogor, Indonesia. The linear growth pattern was described based on birthweight and length status. Birthweight and length status was categorized into normal and Small for Gestational Age (SGA). Changes in LAZs (Δ LAZs) in 0-6 months, 6-12 months, and 12-23 months were calculated. General Linear Model Univariate analysis was conducted to analyze the difference of Δ LAZ between SGA and normal children. Though full-term SGA children have significantly higher linear growth velocity during the first 6 months of the infancy period, full-term SGA children could not catch up with the attained growth/height of normal children throughout the first two years. Thus, full-term SGA children ended up with a higher prevalence of stunted. Both in SGA and normal children, the substantial loss of LAZ occurred between 0-6 months. The finding in this study showed that the first 1000 days of life is still the best period in stunting prevention; however, the stunting prevention program should start earlier, focusing on the first 500 days of life, and potentially the prenatal period.
Sections du résumé
BACKGROUND
Epidemiological studies show that the height-for-age Z-scores (HAZ) falter dramatically shortly after birth until the end of the first two years. Understanding these changes in linear growth in the first two years can help us understand the critical period of child linear growth and propose interventions.
OBJECTIVES
This study objectives were to describe the pattern of linear growth faltering and analyze the changes in length-for-age Z-scores (LAZs) throughout the first two years based on birthweight and length status.
METHODS
This study analyzed 408 children, participants in Longitudinal Study on Child Growth and Development in Bogor, Indonesia. The linear growth pattern was described based on birthweight and length status. Birthweight and length status was categorized into normal and Small for Gestational Age (SGA). Changes in LAZs (Δ LAZs) in 0-6 months, 6-12 months, and 12-23 months were calculated. General Linear Model Univariate analysis was conducted to analyze the difference of Δ LAZ between SGA and normal children.
RESULTS
Though full-term SGA children have significantly higher linear growth velocity during the first 6 months of the infancy period, full-term SGA children could not catch up with the attained growth/height of normal children throughout the first two years. Thus, full-term SGA children ended up with a higher prevalence of stunted. Both in SGA and normal children, the substantial loss of LAZ occurred between 0-6 months.
CONCLUSION
The finding in this study showed that the first 1000 days of life is still the best period in stunting prevention; however, the stunting prevention program should start earlier, focusing on the first 500 days of life, and potentially the prenatal period.
Identifiants
pubmed: 37708204
doi: 10.1371/journal.pone.0291176
pii: PONE-D-23-09470
pmc: PMC10501671
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0291176Informations de copyright
Copyright: © 2023 Kumala Putri et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2016 Jul 21;11(7):e0159461
pubmed: 27441564
J Nutr. 2014 Sep;144(9):1460-6
pubmed: 24944283
Matern Child Nutr. 2016 May;12 Suppl 1:12-26
pubmed: 27187907
Paediatr Perinat Epidemiol. 2012 Jul;26 Suppl 1:302-14
pubmed: 22742617
Nutrients. 2023 Feb 13;15(4):
pubmed: 36839288
BMC Public Health. 2019 Jan 14;19(1):61
pubmed: 30642306
Pediatr Res. 1995 Aug;38(2):267-71
pubmed: 7478827
J Int Med Res. 2021 Dec;49(12):3000605211060672
pubmed: 34855533
Int J Epidemiol. 2013 Oct;42(5):1340-55
pubmed: 23920141
BMC Pediatr. 2015 Oct 06;15:145
pubmed: 26444012
J Nutr. 2002 Aug;132(8):2202-7
pubmed: 12163663
PLoS One. 2020 Sep 8;15(9):e0238700
pubmed: 32898169
Acta Paediatr. 2008 Sep;97(9):1200-4
pubmed: 18616625
Acta Paediatr. 2013 Aug;102(8):787-96
pubmed: 23586744
Am J Clin Nutr. 2016 Dec;104(6):1616-1627
pubmed: 27806980
Am J Clin Nutr. 2020 Sep 14;112(Suppl 2):894S-904S
pubmed: 32692800
Pediatrics. 2010 Mar;125(3):e473-80
pubmed: 20156903
J Pediatr. 2017 Mar;182:127-132.e1
pubmed: 27974166
Adv Nutr. 2019 Jan 1;10(1):104-111
pubmed: 30649167
Breastfeed Med. 2020 Oct;15(10):639-645
pubmed: 32799538
BMC Pediatr. 2022 Feb 1;22(1):73
pubmed: 35105325
BMC Med. 2019 Nov 25;17(1):214
pubmed: 31767012
Early Hum Dev. 2020 Dec;151:105199
pubmed: 33032049
Pediatr Res. 1995 Nov;38(5):733-9
pubmed: 8552442